Conjugate of PAMAM Dendrimer, Doxorubicin and Monoclonal Antibody—Trastuzumab: The New Approach of a Well-Known Strategy

The strategy utilizing trastuzumab, a humanized monoclonal antibody against human epidermal growth receptor 2 (HER-2), as a therapeutic agent in HER-2 positive breast cancer therapy seems to have advantage over traditional chemotherapy, especially when given in combination with anticancer drugs. How...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcinkowska, Monika, Sobierajska, Ewelina, Stanczyk, Maciej, Janaszewska, Anna, Chworos, Arkadiusz, Klajnert-Maculewicz, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414888/
https://www.ncbi.nlm.nih.gov/pubmed/30966223
http://dx.doi.org/10.3390/polym10020187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414888/
https://www.ncbi.nlm.nih.gov/pubmed/30966223
http://dx.doi.org/10.3390/polym10020187

Ejemplares similares